Talphera (TLPH)
Develops hospital and dialysis therapies, led by Niyad for renal-replacement anticoagulation.
$1.20
At close+0.02 (+1.69%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions51 holders · as of Mar 31, 2026 | 42.13% | 21.87M shares | |
| Insiders11 holders · as of Jun 24, 2026 | 2.17% | 1.13M shares | |
| Strategic holders1 holder · as of Sep 12, 2025 | 17.51% | 9.09M shares | |
| Otherremainder | 38.19% | 19.82M shares |
51.91M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
51 holders · 21.87M shares · 12 new positions · 25 increased · 8 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Aigh Capital Management LLC | 4.66M | 8.98% | 0 | Apr 30, 2026 |
| Rock Springs Capital Management LP | 3.59M | 6.91% | 0 | May 15, 2026 |
| Nantahala Capital Management, LLC | 3.49M | 6.73% | 0 | May 15, 2026 |
| Rosalind Advisors, Inc. | 3.35M | 6.46% | −225.4K | May 14, 2026 |
| Bleichroeder LP | 1.31M | 2.52% | +426.6K | May 14, 2026 |
| Cantor Fitzgerald, L. P. | 887.5K | 1.71% | +310.0K | May 15, 2026 |
| Empery Asset Management, LP | 590.5K | 1.14% | −743.0K | May 8, 2026 |
| Caption Management, LLC | 561.8K | 1.08% | +561.8Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| CorMedix Inc. | 19.95% | 9.09M | 13D | Sep 12, 2025 ↗ |
| Nantahala Capital Management, LLCincl. Daniel Mack, Wilmot B. Harkey | 11.70% | 1.99M | 13D | Apr 3, 2025 ↗ |
| Rosalind Advisors, Inc. | 9.90% | 12.93M | 13G | May 12, 2026 ↗ |
| Orin Hirschman | 9.80% | 4.66M | 13G | Jan 30, 2026 ↗ |
| Rock Springs Capital Management LP | 7.88% | 3.59M | 13G | Sep 12, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 13, 2026 | Vincent J. Angottidirector, officer: CHIEF EXECUTIVE OFFICER | Purchase | 213,310 | $0.5860 | 800,705 |
| Feb 12, 2026 | Raffi Asadorianofficer: Chief Financial Officer | Purchase | 45,000 | $0.8123 | 91,256 |
| Feb 12, 2026 | Badri N. Dasuofficer: Chief Engineering Officer | Purchase | 35,000 | $0.8123 | 76,230 |
| Feb 12, 2026 | Shakil Aslamofficer: Chief Medical Officer | Purchase | 35,000 | $0.8123 | 83,178 |
| Feb 12, 2026 | Vincent J. Angottidirector, officer: CHIEF EXECUTIVE OFFICER | Purchase | 105,364 | $0.8123 | 586,954 |
CongressHouse and Senate disclosures
Not reported.